{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:03:22Z","timestamp":1782983002642,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100846"],"award-info":[{"award-number":["82100846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170870"],"award-info":[{"award-number":["82170870"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82120108008"],"award-info":[{"award-number":["82120108008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["20YF1423500"],"award-info":[{"award-number":["20YF1423500"]}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19140902400"],"award-info":[{"award-number":["19140902400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC2020CR4006"],"award-info":[{"award-number":["SHDC2020CR4006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We aimed to investigate the differences of metabolic disorders between the general population and psychiatric patients, with an emphasis on the prevalence and influencing factors of liver fibrosis in psychiatric patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 734 psychiatric patients and 734 general population matched for age, sex, and BMI were enrolled from Shanghai, China. All participants underwent blood pressure, glucose, lipid profile measurements, and anthropometric parameters including body weight, height and waist circumference. FibroScan examinations were also performed on psychiatric patients. Liver steatosis and fibrosis were diagnosed by controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) by professional staff.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared with the general population, psychiatric patients revealed significantly higher burden of metabolic disorders. The overall prevalence of liver steatosis (CAP\u2009\u2265\u2009233 dB\/m) and fibrosis (LSM\u2009\u2265\u20097.0\u00a0kPa) was 48.7% and 15.5% in psychiatric patients. Psychiatric patients with liver steatosis or fibrosis showed worse metabolic profile. Meanwhile, the prevalence of liver fibrosis was also significantly higher in patients with overweight, central obesity, diabetes, hypertension, metabolic syndrome, and liver steatosis. In logistic regression analyses, age, BMI and visceral adiposity index were independent risk factors for liver fibrosis in psychiatric patients. Additionally, antipsychotic medication was suggested to be associated with an increased risk of liver fibrosis in psychiatric patients with liver steatosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Prevalence of liver steatosis and fibrosis is high in Chinese psychiatric patients. Those with antipsychotic polypharmacy and obesity are at high risk, and may benefit from early liver assessment in preventing fibrosis progression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-023-04684-1","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T14:02:59Z","timestamp":1680012179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["High prevalence of metabolic diseases, liver steatosis and fibrosis among Chinese psychiatric patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Huixia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"issue":"2","key":"4684_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/ije\/dyu038","volume":"43","author":"Z Steel","year":"2014","unstructured":"Steel Z, Marnane C, Iranpour C, Chey T, Jackson JW, Patel V, Silove D. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980\u20132013. Int J Epidemiol. 2014;43(2):476\u201393.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"4684_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","volume":"6","author":"Y Huang","year":"2019","unstructured":"Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, Yu Y, Kou C, Xu X, Lu J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211\u201324.","journal-title":"Lancet Psychiatry"},{"key":"4684_CR3","doi-asserted-by":"crossref","unstructured":"Richmond G, Kenny C, Ahmed J, Stephenson L, Lindsay J, Earls P, Mullin D, Ryland H. Health Education and Activity - Lessening The Inequalities in mental health (HEA - LTI mental health).BMJ Qual Improv Rep2017, 6(1).","DOI":"10.1136\/bmjquality.u205156.w3484"},{"issue":"5","key":"4684_CR4","doi-asserted-by":"publisher","first-page":"e19590","DOI":"10.1371\/journal.pone.0019590","volume":"6","author":"CK Chang","year":"2011","unstructured":"Chang CK, Hayes RD, Perera G, Broadbent MT, Fernandes AC, Lee WE, Hotopf M, Stewart R. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS ONE. 2011;6(5):e19590.","journal-title":"PLoS ONE"},{"issue":"4","key":"4684_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","volume":"72","author":"ER Walker","year":"2015","unstructured":"Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334\u201341.","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"4684_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","volume":"196","author":"S Brown","year":"2010","unstructured":"Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry. 2010;196(2):116\u201321.","journal-title":"Br J Psychiatry"},{"key":"4684_CR7","doi-asserted-by":"publisher","first-page":"f2539","DOI":"10.1136\/bmj.f2539","volume":"346","author":"D Lawrence","year":"2013","unstructured":"Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in western Australia: retrospective analysis of population based registers. BMJ. 2013;346:f2539.","journal-title":"BMJ"},{"issue":"6","key":"4684_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.eurpsy.2009.01.005","volume":"24","author":"M De Hert","year":"2009","unstructured":"De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Moller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the european Psychiatric Association (EPA), supported by the European Association for the study of diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009;24(6):412\u201324.","journal-title":"Eur Psychiatry"},{"issue":"7","key":"4684_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1176\/appi.ajp.2017.17040409","volume":"174","author":"OA Andreassen","year":"2017","unstructured":"Andreassen OA. Diabetes and Schizophrenia-New Findings for an old puzzle. Am J Psychiatry. 2017;174(7):616\u20137.","journal-title":"Am J Psychiatry"},{"key":"4684_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1471-244X-11-159","volume":"11","author":"D Jakabek","year":"2011","unstructured":"Jakabek D, Quirk F, Driessen M, Aljeesh Y, Baune BT. Obesity and nutrition behaviours in western and palestinian outpatients with severe mental illness. BMC Psychiatry. 2011;11:159.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"4684_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41569-020-00463-7","volume":"18","author":"RE Nielsen","year":"2021","unstructured":"Nielsen RE, Banner J, Jensen SE. Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol. 2021;18(2):136\u201345.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"4684_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/wps.20252","volume":"14","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, Rosenbaum S, Correll CU. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World psychiatry: official journal of the World Psychiatric Association (WPA). 2015;14(3):339\u201347.","journal-title":"World psychiatry: official journal of the World Psychiatric Association (WPA)"},{"issue":"6","key":"4684_CR13","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/hep.28394","volume":"63","author":"C Cassinotto","year":"2016","unstructured":"Cassinotto C, Boursier J, de Ledinghen V, Lebigot J, Lapuyade B, Cales P, Hiriart JB, Michalak S, Bail BL, Cartier V, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology. 2016;63(6):1817\u201327.","journal-title":"Hepatology"},{"issue":"1","key":"4684_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hep.24376","volume":"54","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, Ratziu V, McCullough A. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54(1):344\u201353.","journal-title":"Hepatology"},{"issue":"2","key":"4684_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P A ngulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389\u201397.","journal-title":"Gastroenterology"},{"issue":"3","key":"4684_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"Y ounossi ZM","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019;70(3):531\u201344.","journal-title":"J Hepatol"},{"key":"4684_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"PSA Kountouras","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397.","journal-title":"Metabolism"},{"issue":"4","key":"4684_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","volume":"7","author":"S tefan","year":"2019","unstructured":"Stefan N, H\u00e4ring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7(4):313\u201324.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"4684_CR19","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u201353.","journal-title":"Gut"},{"issue":"3","key":"4684_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745\u201350.","journal-title":"Gastroenterology"},{"issue":"11","key":"4684_CR21","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1440-1746.2010.06437.x","volume":"25","author":"VW Wong","year":"2010","unstructured":"Wong VW, Chan HL. Transient elastography. J Gastroenterol Hepatol. 2010;25(11):1726\u201331.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"4684_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.clnu.2015.11.010","volume":"36","author":"N Wang","year":"2017","unstructured":"Wang N, Wang X, Li Q, Han B, Chen Y, Zhu C, Chen Y, Lin D, Wang B, Jensen MD, et al. The famine exposure in early life and metabolic syndrome in adulthood. Clin Nutr. 2017;36(1):253\u20139.","journal-title":"Clin Nutr"},{"issue":"12","key":"4684_CR23","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1089\/thy.2017.0385","volume":"27","author":"C Chen","year":"2017","unstructured":"Chen C, Xu H, Chen Y, Chen Y, Li Q, Hu J, Liang W, Cheng J, Xia F, Wang C, et al. Iodized Salt Intake and its association with urinary iodine, Thyroid Peroxidase Antibodies, and Thyroglobulin Antibodies Among Urban Chinese. Thyroid. 2017;27(12):1566\u201373.","journal-title":"Thyroid"},{"issue":"8","key":"4684_CR24","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1210\/jc.2018-01874","volume":"104","author":"C Chen","year":"2019","unstructured":"Chen C, Zhai H, Cheng J, Weng P, Chen Y, Li Q, Wang C, Xia F, Wang N, Lu Y. Causal link between vitamin D and total testosterone in men: a mendelian randomization analysis. J Clin Endocrinol Metab. 2019;104(8):3148\u201356.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4684_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-020-01095-4","volume":"19","author":"H Wan","year":"2020","unstructured":"Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C, Zhang W, Zhang H, Xia F, Wang N, et al. Associations between abdominal obesity indices and diabetic complications: chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118.","journal-title":"Cardiovasc Diabetol"},{"key":"4684_CR26","doi-asserted-by":"publisher","first-page":"113663","DOI":"10.1016\/j.ijheh.2020.113663","volume":"231","author":"H Wan","year":"2021","unstructured":"Wan H, Chen S, Cai Y, Chen Y, Wang Y, Zhang W, Chen C, Wang N, Guo Y, Lu Y. Lead exposure and its association with cardiovascular disease and diabetic kidney disease in middle-aged and elderly diabetic patients. Int J Hyg Environ Health. 2021;231:113663.","journal-title":"Int J Hyg Environ Health"},{"key":"4684_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12986-020-00493-5","volume":"17","author":"C Chen","year":"2020","unstructured":"Chen C, Chen Y, Zhai H, Xia F, Han B, Zhang W, Wang Y, Wan H, Wang N, Lu Y. Iodine nutrition status and its association with microvascular complications in urban dwellers with type 2 diabetes. Nutr Metab (Lond). 2020;17:70.","journal-title":"Nutr Metab (Lond)"},{"issue":"1","key":"4684_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12944-018-0739-z","volume":"17","author":"L Zhao","year":"2018","unstructured":"Zhao L, Huang G, Xia F, Li Q, Han B, Chen Y, Chen C, Lin D, Wang N, Lu Y. Neck circumference as an independent indicator of visceral obesity in a Chinese population. Lipids Health Dis. 2018;17(1):85.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"4684_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2893.2011.01534.x","volume":"19","author":"M Sasso","year":"2012","unstructured":"Sasso M, Tengher-Barna I, Ziol M, Miette V, Fournier C, Sandrin L, Poupon R, Cardoso AC, Marcellin P, Douvin C, et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C. J Viral Hepat. 2012;19(4):244\u201353.","journal-title":"J Viral Hepat"},{"issue":"2","key":"4684_CR30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.23312","volume":"51","author":"VW Wong","year":"2010","unstructured":"Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Choi PC, Kowo M, Chan AW, Merrouche W, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51(2):454\u201362.","journal-title":"Hepatology"},{"issue":"9491","key":"4684_CR31","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KGMM Alberti","year":"2005","unstructured":"Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome\u2014a new worldwide definition. The Lancet. 2005;366(9491):1059\u201362.","journal-title":"The Lancet"},{"key":"4684_CR32","doi-asserted-by":"crossref","unstructured":"Rostama B, Beauchemin M, Bouchard C, Bernier E, Vary CPH, May M, Houseknecht KL. Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. Int J Mol Sci 2020, 21(24).","DOI":"10.3390\/ijms21249362"},{"issue":"2","key":"4684_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.genhosppsych.2013.11.002","volume":"36","author":"DJ Stein","year":"2014","unstructured":"Stein DJ, Aguilar-Gaxiola S, Alonso J, Bruffaerts R, de Jonge P, Liu Z, Miguel Caldas-de-Almeida J, O\u2019Neill S, Viana MC, Al-Hamzawi AO, et al. Associations between mental disorders and subsequent onset of hypertension. Gen Hosp Psychiatry. 2014;36(2):142\u20139.","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"4684_CR34","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1192\/j.eurpsy.2020.94","volume":"63","author":"V Salvi","year":"2020","unstructured":"Salvi V, Aguglia A, Barone-Adesi F, Bianchi D, Donfrancesco C, Dragogna F, Palmieri L, Serafini G, Amore M, Mencacci C. Cardiovascular risk in patients with severe mental illness in Italy. Eur Psychiatry. 2020;63(1):e96.","journal-title":"Eur Psychiatry"},{"issue":"3","key":"4684_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2468-1253(19)30419-4","volume":"5","author":"KWM Abeysekera","year":"2020","unstructured":"Abeysekera KWM, Fernandes GS, Hammerton G, Portal AJ, Gordon FH, Heron J, Hickman M. Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study. Lancet Gastroenterol Hepatol. 2020;5(3):295\u2013305.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"4684_CR36","doi-asserted-by":"publisher","first-page":"e2856","DOI":"10.1210\/clinem\/dgab262","volume":"106","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Muraca E, Zerbini F, Manzoni G, Perseghin G. NAFLD and Liver Fibrosis are not Associated with reduced femoral bone Mineral Density in the General US Population. J Clin Endocrinol Metab. 2021;106(8):e2856\u201365.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4684_CR37","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s12072-021-10195-6","volume":"15","author":"MR Braude","year":"2021","unstructured":"Braude MR, Con D, Lubel J, Bidwai A, Nguyen HT, Sharmamiglani S, Clarke D, Dev A, Sievert W. Liver disease prevalence and severity in people with serious mental illness: a cross-sectional analysis using non-invasive diagnostic tools. Hepatol Int. 2021;15(3):812\u201320.","journal-title":"Hepatol Int"},{"issue":"8","key":"4684_CR38","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2174\/1570159X15666170630163616","volume":"16","author":"S Siafis","year":"2018","unstructured":"Siafis S, Tzachanis D, Samara M, Papazisis G. Antipsychotic drugs: from receptor-binding profiles to Metabolic Side Effects. Curr Neuropharmacol. 2018;16(8):1210\u201323.","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"4684_CR39","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/MED.0b013e32833de61c","volume":"17","author":"P Pramyothin","year":"2010","unstructured":"Pramyothin P, Khaodhiar L. Metabolic syndrome with the atypical antipsychotics. Curr Opin Endocrinol Diabetes Obes. 2010;17(5):460\u20136.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"4684_CR40","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","volume":"65","author":"R Kwok","year":"2016","unstructured":"Kwok R, Choi KC, Wong GL, Zhang Y, Chan HL, Luk AO, Shu SS, Chan AW, Yeung MW, Chan JC, et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut. 2016;65(8):1359\u201368.","journal-title":"Gut"},{"issue":"1","key":"4684_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2014.08.041","volume":"62","author":"VW Wong","year":"2015","unstructured":"Wong VW, Wong GL, Yeung DK, Lau TK, Chan CK, Chim AM, Abrigo JM, Chan RS, Woo J, Tse YK, et al. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J Hepatol. 2015;62(1):182\u20139.","journal-title":"J Hepatol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04684-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-023-04684-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04684-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T14:03:48Z","timestamp":1680012228000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-023-04684-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4684"],"URL":"https:\/\/doi.org\/10.1186\/s12888-023-04684-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine approved the study, and all participants provided a written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflicts of interest relevant to this article were reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}